Therapeutic-products United States

Proteome Systems Limited is an Australia-based company. The Company, along with its subsidiaries, is principally engaged in biomarker discovery for development of new diagnostics in the areas of respiratory and infectious disease, and cancer; commercialization ...

Proteome Systems Limited is an Australia-based company. The Company, along with its subsidiaries, is principally engaged in biomarker discovery for development of new diagnostics in the areas of respiratory and infectious disease, and cancer; commercialization ...

Lev is a biopharmaceutical company focused on developing and commercializing therapeutic products for the treatment of inflammatory diseases. Lev's lead product candidate, Cinryze (C1 inhibitor), is being developed as a replacement therapy both for the ...

AGI (the company) is a specialty pharmaceutical company which is focused on the development and commercialisation of differentiated drug products for gastrointestinal (GI) diseases and disorders. AGI's common shares are listed on the Alternative Investment ...

AusAm is developing a new class of anti-viral compounds known as attachment inhibitors. Our attachment inhibitors are polysaccharide-based compounds that prevent a virus from attaching to and infecting its target cell. AusAm's lead anti-viral compound ...

Lev is a biopharmaceutical company focused on developing and commercializing therapeutic products for the treatment of inflammatory diseases. Lev's lead product candidate, Cinryze (C1 inhibitor), is being developed as a replacement therapy both for the ...

"Bone Care International, Inc. is an innovative pharmaceutical company dedicated to improving patient outcomes by delivering unsurpassed Vitamin D hormone therapies. Bone Care International, Inc. is committed to discovering, developing and commercializing ...

Providers of biotechnology in Kalamazoo

BrainStorm (OTC BB: BCLI) is a company that is developing stem cell technologies to provide treatments for currently incurable neurodegenerative diseases. The Company is focused on developing adult stem cells taken from the patient's own bone marrow to ...

Gliatech Inc. (NASDAQ: GLIA) was founded in 1988 to discover, develop, and commercialize therapeutic products based on the properties of glial cells. Glial cells perform key roles in the formation and function of the central nervous system (CNS). Gliatech ...

ICOS is a product-driven company that has expertise in both protein-based and small molecule therapeutics. ICOS combines its capabilities in molecular, cellular and structural biology, high throughput drug screening, medicinal chemistry and gene expression ...

"Bone Care International, Inc. is an innovative pharmaceutical company dedicated to improving patient outcomes by delivering unsurpassed Vitamin D hormone therapies. Bone Care International, Inc. is committed to discovering, developing and commercializing ...

BrainStorm (OTC BB: BCLI) is a company that is developing stem cell technologies to provide treatments for currently incurable neurodegenerative diseases. The Company is focused on developing adult stem cells taken from the patient's own bone marrow to ...

ContraVac, located in Charlottesville, VA, develops products for male reproductive healthcare in cooperation with the Center for Research in Contraceptive and Reproductive Health at the University of Virginia which is directed by ContraVac's founder, Dr ...

Aqua Bounty Technologies, Inc. is engaged in providing biotechnology-based products to the aquaculture industry. It sells therapeutic and diagnostic products to the aquaculture industry. Substantially all of its product revenues are derived from sales ...

Quintessence Biosciences, Inc. is a biopharmaceutical company focused on development of novel protein-based therapeutics as anti-cancer agents. The Company's products are based on the EVadeÔ Ribonuclease Technology which allows for the engineering of ...

Zelos Therapeutics specializes in the development of innovative treatments for bone disorders and related indications in large, underserved markets. Led by an experienced team of biopharmaceutical executives and funded by leading health care investors ...

GenPhar, Inc. is a biopharmaceutical company dedicated to becoming a leader in developing and producing prophylactic and therapeutic vaccines to protect against the world's most dangerous diseases. To reach its goals, GenPhar will leverage the advantage ...

Cognetix is a private drug discovery and development company located in Salt Lake City, Utah, focused on commercializing conopeptide-based pharmaceuticals. Conopeptides are bioactive peptides in the venom of marine cone snails. The Company is currently ...

Quintessence Biosciences, Inc. is a biopharmaceutical company focused on development of novel protein-based therapeutics as anti-cancer agents. The Company's products are based on the EVadeÔ Ribonuclease Technology which allows for the engineering of ...

Alvine Pharmaceuticals is developing innovative therapeutic and diagnostic products for the treatment of celiac sprue, a gluten-induced autoimmune disease for which no drug therapy is presently available. Founded in 2005, and based on technology created ...

GenPhar, Inc. is a biopharmaceutical company dedicated to becoming a leader in developing and producing prophylactic and therapeutic vaccines to protect against the world's most dangerous diseases. To reach its goals, GenPhar will leverage the advantage ...

SLIL is a world leader in the field of polyamine analog research and is developing new therapies for cancer and other diseases. SLIL also has an exclusive license to the Sequential Pathogenesis technology and has the opportunity to develop therapeutic ...

Zelos Therapeutics specializes in the development of innovative treatments for bone disorders and related indications in large, underserved markets. Led by an experienced team of biopharmaceutical executives and funded by leading health care investors ...

ContraVac, located in Charlottesville, VA, develops products for male reproductive healthcare in cooperation with the Center for Research in Contraceptive and Reproductive Health at the University of Virginia which is directed by ContraVac's founder, Dr ...